| RS2149300813 |
DNMT3A
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2149301822 |
DOCK7
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149303071 |
CAMTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS2149303084 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2149303175 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2149307214 |
DNMT3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neonatal hypotonia, Autism spectrum disorder |
| RS2149307985 |
DNMT3A
|
Health Risk |
Likely pathogenic |
Heyn-Sproul-Jackson syndrome, Heyn-Sproul-Jackson syndrome |
| RS2149312917 |
MYO6
|
Health Risk |
Pathogenic |
— |
| RS2149314726 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149320961 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149321922 |
MYO6
|
Health Risk |
Pathogenic/Likely pathogenic |
MYO6-related disorder, MYO6-related disorder |
| RS2149322991 |
COL12A1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2149323203 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2149323564 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2149323575 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2149323618 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2149323799 |
MMACHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2149323805 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2149323826 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2149323855 |
MMACHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2149323872 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2149323994 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2149325212 |
PAK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 30 |
| RS2149331785 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS2149337320 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS2149340429 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149341072 |
USP53
|
Health Risk |
Likely pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS2149344192 |
COL12A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 2, Ullrich congenital muscular dystrophy 2 |
| RS2149347262 |
PRDM5
|
Health Risk |
Pathogenic |
— |
| RS2149347420 |
MYO6
|
Health Risk |
Pathogenic |
— |
| RS2149347624 |
COL12A1
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS2149347766 |
MYO6
|
Health Risk |
Likely pathogenic |
Hearing impairment, Hearing impairment |
| RS2149349312 |
COL12A1
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS2149349423 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149349537 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149349862 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149350038 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149350070 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149350132 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149350164 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149350194 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149350253 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Dilated cardiomyopathy 3B |
| RS2149350391 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149350435 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149352030 |
RYR2
|
Health Risk |
Pathogenic |
Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome, Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome |
| RS2149352927 |
COL12A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS2149353116 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149353940 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149354389 |
RYR2
|
Health Risk |
Likely pathogenic |
Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149354441 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149356861 |
CNGB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149357361 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2149358455 |
CNGB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 45, Retinitis pigmentosa 45 |
| RS2149358561 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2149358592 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 45, Retinitis pigmentosa 45 |
| RS2149358928 |
MYO6
|
Health Risk |
Likely pathogenic |
— |
| RS2149359004 |
MYO6
|
Health Risk |
Pathogenic |
— |
| RS2149359022 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 45, Retinitis pigmentosa 45 |
| RS2149359033 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 45, Retinitis pigmentosa 45 |
| RS2149360884 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy, Nemaline myopathy |
| RS2149362043 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2149364126 |
CNGB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149364141 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2149364812 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2149364869 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2149365348 |
DNMT3A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2149365370 |
DNMT3A
|
Health Risk |
Pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS2149365500 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2149365820 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2149366496 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2149366536 |
CNGB1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2149367858 |
MYO6
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 37, Autosomal recessive nonsyndromic hearing loss 37 |
| RS2149367866 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2149368227 |
MYO6
|
Health Risk |
Pathogenic |
— |
| RS2149368742 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2149369481 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS2149371436 |
PDE8B
|
Health Risk |
Pathogenic |
— |
| RS2149371451 |
PDE8B
|
Health Risk |
Pathogenic |
Autosomal dominant striatal neurodegeneration type 1, Autosomal dominant striatal neurodegeneration type 1 |
| RS2149371468 |
PDE8B
|
Health Risk |
Pathogenic |
— |
| RS2149372033 |
CNGB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 45, Retinitis pigmentosa 45 |
| RS2149372690 |
COL12A1
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS2149373593 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS2149374086 |
USP53
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS2149375770 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2149377370 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149378392 |
DEPDC5
|
Health Risk |
Pathogenic |
— |
| RS2149381577 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS2149382649 |
PPP2CA
|
Health Risk |
Pathogenic |
— |
| RS2149382671 |
PPP2CA
|
Health Risk |
Likely pathogenic |
— |
| RS2149383143 |
PPP2CA
|
Health Risk |
Pathogenic |
Houge-Janssens syndrome 3, Houge-Janssens syndrome 3 |
| RS2149383148 |
PPP2CA
|
Health Risk |
Pathogenic |
— |
| RS2149383411 |
PPP2CA
|
Health Risk |
Pathogenic |
— |
| RS2149383419 |
PPP2CA
|
Health Risk |
Conflicting classifications of pathogenicity |
Houge-Janssens syndrome 3, Houge-Janssens syndrome 3 |
| RS2149383774 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149384599 |
PPP2CA
|
Health Risk |
Likely pathogenic |
— |
| RS2149388002 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2149388042 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149388137 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149389813 |
USP53
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS2149390162 |
WDFY3
|
Health Risk |
Likely pathogenic |
Macrocephaly, Microcephaly 18 |